Arvee Laboratories promoters report no share encumbrances in FY26
Arvee Laboratories (India) Limited disclosed that its promoters and persons acting in concert did not encumber any shares during the financial year ended March 31, 2026, other than those previously declared. The filing was submitted to the National Stock Exchange of India Limited in compliance with Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeover) Regulations, 2011. The disclosure included a list of 13 individuals and entities forming the promoter and promoter group.

*this image is generated using AI for illustrative purposes only.
Arvee Laboratories (India) Limited confirmed that its promoters and persons acting in concert did not encumber any shares during the financial year ended March 31, 2026, aside from those already declared. The disclosure, submitted to the National Stock Exchange of India Limited, was made in compliance with Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeover) Regulations, 2011. This regulatory requirement mandates the disclosure of any encumbrance on shares held by the promoter group to ensure transparency for shareholders.
The filing, dated April 7, 2026, was signed by Shalin Sudhakarbhai Patel on behalf of the promoters and promoter group. The document explicitly stated that no new encumbrances were created during the year under review. The submission included an annexure listing the names and categories of all individuals and entities comprising the promoter and promoter group.
The promoter group consists of 13 members, including both individuals and Hindu Undivided Families (HUFs). Shalin Sudhakarbhai Patel and Shalin Bharatbhai Chokshi are listed as Promoters, while the remaining members, such as Sudhakar Chhotabhai Patel HUF and Mitaben Bharatbhai Chokshi, are classified under the Promoter Group category.
Promoter and Promoter Group Details
| Sr. No | Name of Promoter / Promoter Group | Category |
|---|---|---|
| 1 | SHALIN SUDHAKARBHAI PATEL | Promoter |
| 2 | MITABEN BHARATBHAI CHOKSHI | Promoter Group |
| 3 | SHALIN BHARATBHAI CHOKSHI | Promoter |
| 4 | SUDHAKAR CHHOTABHAI PATEL HUF | Promoter Group |
| 5 | SHALINBHAI SUDHAKARBHAI PATEL HUF | Promoter Group |
| 6 | CHANDRABALABEN PATEL | Promoter Group |
| 7 | FORUM SAUMIL CHOKSHI | Promoter Group |
| 8 | KAVITA SHALIN CHOKSHI | Promoter Group |
| 9 | KHUSHBUBEN SHALINBHAI PATEL | Promoter Group |
| 10 | BHARAT RASIKLAL CHOKSHI | Promoter Group |
| 11 | SAUMIL BHARATBHAI CHOKSHI | Promoter Group |
| 12 | DHAVAL SUNILBHAI THAKKAR | Promoter Group |
| 13 | VEER SHALIN PATEL | Promoter Group |
The disclosure provides assurance to the market regarding the financial standing of the company's key shareholders by confirming the absence of additional liens or charges on their holdings during the specified period.
Historical Stock Returns for Arvee Laboratories
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -1.36% | +0.11% | +7.52% | -35.23% | +2.73% | +47.33% |
How will the market interpret this clean disclosure regarding the promoters' financial health in the context of the company's future capital requirements?
Does the absence of new encumbrances suggest that the promoters are prioritizing retaining ownership over raising personal capital for new ventures?
Could this financial stability of the promoter group position Arvee Laboratories as a more attractive candidate for strategic partnerships or acquisitions?

























